MedTrace Logo

An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of Vedolizumab

NCT06855862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-03-04

No results posted yet for this study

Summary

It is uncertain the relationship between serum cytokine levels and the clinical efficacy of vedolizumab in the treatment of ulcerative colitis. The effects of cytokines on the efficacy of vidrecizumab in Chinese UC patients were retrospectively analyzed. Methods: Patients with UC were recorded. These patients were detected the levels of cytokines.

Conditions

  • Ulcerative Colitis (UC)

Sponsors & Collaborators

  • Second Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-05
Primary Completion
2024-02-02
Completion
2024-02-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06855862 on ClinicalTrials.gov